跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55 条关于
“MAP2K1”
全部
55
临床试验
39
药物
10
机构
0
资讯
6
去年
Amivantamab Shows Promise in Colorectal Cancer as Phase 3 Trials Launch Following Encouraging Phase 1b/2 Results
去年
BREAKWATER Study Reveals ctDNA Clearance Predicts Survival in BRAF V600E-Mutant Colorectal Cancer
去年
PAS-004 Shows Favorable Safety and Early Efficacy in MAPK-Driven Solid Tumors
8个月前
Derazantinib Enhances Gemcitabine Efficacy in Pancreatic Cancer by Suppressing NF-κB and MAPK Pathways
去年
Immuneering Partners with Lilly for Phase 2 NSCLC Combination Trial Testing Dual MAPK Pathway Blockade
2年前
Nested Therapeutics' NST-628: A Novel Pan-RAF–MEK Molecular Glue for MAPK Pathway Inhibition